Gut microecology in critical illness: mechanisms, biomarkers, and therapeutic strategies — a critical appraisal
Frontiers in Gastroenterology · 05.08.2026 · 5
DOI: 10.3389/fgstr.2026.1902608 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Gastroenterology, online erschienen am 05.08.2026. Verfasst von Liang Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shanghai Deji Hospital, Qingdao University, Shanghai, China. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Critical illness is associated with a predictable ecological collapse of the gut microbiome. Within 48 hours of ICU admission, three convergent selective pressures—luminal oxygen enrichment from mucosal inflammation, nitrate provision by iNOS, and antibiotic-mediated niche clearance—drive a phase transition from obligate-anaerobe-dominated communities to pathogen-dominated monocultures, compromising barrier integrity and immune homeostasis. Multi-omics integration recasts this as a cross-kingdom phenomenon encompassing fungi, bacteriophages, and the metabolite networks linking them to host immunity. Whether this collapse directly causes organ dysfunction or merely marks disease severity remains the central unresolved question. This critical review examines evidence across six domains: the healthy microbiota as an ecological benchmark; patterns and temporal dynamics of ICU dysbiosis; molecular mechanisms across four gut–organ axes; clinical consequences including sepsis, nosocomial infection, acute gastrointestinal injury, and multiple organ dysfunction syndrome (MODS); biomarkers and machine-learning predictive models; and therapeutic strategies evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. Only early enteral nutrition (GRADE: HIGH) and antimicrobial stewardship (GRADE: MODERATE–HIGH) have Phase III evidence supporting routine ICU use. The repeated failures of probiotic trials reflect design limitations—lack of patient stratification, strain mismatch, and soft endpoints—though biological efficacy limitations cannot be excluded. We conclude that ICU dysbiosis is best understood as ecosystem collapse driven by convergent selective pressures, not random taxonomic disturbance. Therapeutic strategies should target functional outputs—SCFAs, bile acids, indole derivatives—rather than species composition. The resilient minority (15–20% of patients who maintain diversity) holds keys to prevention science. A clinically actionable platform requires three components: rapid ecological risk assessment, endotype classification, and mortality-powered randomized controlled trials targeting functional restoration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Shanghai Deji Hospital, Qingdao University, Shanghai, China.
- Department of Intestinal Microecology, Shanghai Deji Hospital, Qingdao University, Shanghai, China.
- Intensive Care Unit, Shanghai Deji Hospital, Qingdao University, Shanghai, China.
Zitieren
APA
Tian, L., Xu, S., Xie, X., Wang, M., & Huang, L. (2026). Gut microecology in critical illness: mechanisms, biomarkers, and therapeutic strategies — a critical appraisal. Frontiers in Gastroenterology, 5. https://doi.org/10.3389/fgstr.2026.1902608
Vancouver
Tian L, Xu S, Xie X, Wang M, Huang L. Gut microecology in critical illness: mechanisms, biomarkers, and therapeutic strategies — a critical appraisal. Frontiers in Gastroenterology. 2026;5. doi:10.3389/fgstr.2026.1902608
BibTeX
@article{Tian2026,
author = {Tian, Liang and Xu, Shanshan and Xie, Xueping and Wang, Man and Huang, Lina},
title = {Gut microecology in critical illness: mechanisms, biomarkers, and therapeutic strategies — a critical appraisal},
journal = {Frontiers in Gastroenterology},
year = {2026},
volume = {5},
doi = {10.3389/fgstr.2026.1902608}
}
EUVIMED